Skip to main content

Table 1 Socio-demographic and clinical characteristics of African American and non-Hispanic white American colon cancer patients in California, 1996-2000

From: Lack of access to chemotherapy for colon cancer: multiplicative disadvantage of being extremely poor, inadequately insured and African American

 

African American, No. (%)

Non-Hispanic White, No. (%)

Age at diagnosis,** y

  25 - 59

129

28.1

563

18.8

  60 - 69

99

21.6

629

21.0

  70 - 79

138

30.1

980

32.7

  ≥ 80

93

20.3

829

27.6

Women**

275

59.9

1,574

52.4

Neighborhood poverty prevalence,**%

    

  < 5

31

6.8

1,240

41.3

  5 - 29

76

16.6

1,131

37.7

  ≥ 301

352

76.7

630

21.0

Primary health insurers**

    

  Private

194

42.3

1,409

47.0

  Medicare

201

43.8

1,391

46.4

  Medicaid

36

7.8

72

2.4

  Uninsured

28

6.1

129

4.3

Stage at diagnosis

    

  II

184

40.1

1,270

42.3

  III

132

28.8

927

30.9

  IV

143

31.2

804

26.8

Tumor grade

    

  I

31

7.4

192

6.8

  II

286

68.4

1,863

66.4

  III or IV2

101

24.2

752

26.8

  Missing data*

41

8.9

194

6.5

Examined 12 or more RLN3

124

40.4

939

44.1

  Missing data

9

2.8

67

3.0

Received chemotherapy*

145

31.7

1,124

37.6

  Missing data

2

0.4

9

0.3

  1. Note. RLN, Regional lymph nodes.
  2. 1Median annual household income for extremely poor AA ($22,600) and NHWA ($23,650) subsamples; median test [32], χ2 (1, N = 982) = 5.51, p < .05.
  3. 2Only 23 (0.7%) of the tumors were undifferentiated or grade IV.
  4. 3Stage IV metastasized disease excluded.
  5. * p < .10 and ** p < .05 for between-ethnic group difference (χ2 test).